Allogene Therapeutics, Inc. logo ALLO - Allogene Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 19
HOLD 10
SELL 1
STRONG
SELL
0
| PRICE TARGET: $6.43 DETAILS
HIGH: $9.00
LOW: $3.85
MEDIAN: $6.42
CONSENSUS: $6.43
UPSIDE: 221.50%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4
Revenue
Revenue 0 0 0 0 0 0 0 0 0.0 (0.0) 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 38.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 2.9 3.1 31.2 0 3.1 3.2 0 0 3.6 0 3.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (2.9) (3.1) (31.2) 0 (3.1) (3.2) 0 0 (3.5) (0.0) (3.5) 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 38.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 29.1 28.6 31.2 40.2 50.2 45.0 44.7 50.4 52.3 54.7 46.0 62.0 80.2 75.4 63.6 57.2 60.2 54.0 58.7 52.3 55.2 52.2 51.4 47.3 42.0 49.4 40.0 31.8 23.4 18.5 10.9 122.5 0 0
SG&A Expenses 14.1 13.8 13.7 14.3 15.0 15.5 16.3 16.1 17.3 17.2 17.0 18.5 18.9 21.0 18.9 19.5 19.9 20.0 19.0 18.8 16.4 17.1 16.6 15.9 15.6 15.2 15.0 14.2 13.1 14.5 11.3 12.5 2.6 0.0
Other Expenses 0 (3.1) (31.2) 2.4 (3.1) (3.2) 10.7 5.0 (3.6) 13.2 (3.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 43.2 39.3 13.7 56.8 62.1 57.3 71.8 71.4 66.0 85.1 59.4 80.6 99.1 96.4 82.5 76.7 80.1 73.9 77.7 71.1 71.5 69.4 68.0 63.2 57.7 64.6 55.0 46.0 36.5 33.0 22.2 135.0 2.6 0.0
Operating Income
Operating Income (46.1) (42.4) (44.9) (56.8) (65.2) (60.5) (71.8) (71.4) (69.5) (85.2) (63.0) (80.5) (99.1) (96.4) (82.5) (76.6) (80.0) (73.9) (77.7) (71.0) (33.2) (69.4) (68.0) (63.2) (57.7) (64.6) (55.0) (46.0) (36.5) (33.0) (22.2) (135.0) (2.6) (0.0)
Interest Expense 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0
Interest Income 3.6 3.7 0 6.2 5.5 3.0 6.7 5.0 5.4 6.3 6.2 3.8 2.1 2.8 1.0 0.3 0.5 0.2 0.4 0.6 0.5 1.6 2.0 2.3 3.3 3.7 4.3 4.6 4.8 4.2 1.5 0.1 0 0
Profitability
EBITDA (43.2) (39.3) (38.0) (47.6) (56.5) (56.2) (63.0) (62.7) (61.4) (68.5) (58.7) (76.9) (95.6) (93.3) (78.6) (72.9) (76.3) (69.7) (75.3) (69.1) (31.3) (59.5) (66.2) (61.3) (55.6) (59.3) (53.7) (44.8) (35.8) (30.1) (39.6) (134.6) (2.6) (0.0)
EBIT (46.1) (42.4) (41.1) (50.7) (59.6) (59.4) (66.2) (66.4) (65) (71.9) (62.3) (80.5) (99.1) (96.4) (82.5) (76.6) (80.0) (73.9) (77.7) (71.0) (33.2) (61.3) (68.0) (63.2) (57.7) (61.2) (55.0) (46.0) (36.5) (30.6) (40.1) (135.0) (2.6) (0.0)
Income Before Tax (42.6) (38.8) (41.4) (50.9) (59.7) (59.5) (66.3) (66.4) (65) (89.3) (62.3) (79.2) (100.0) (94.8) (83.1) (74.8) (79.8) (74.9) (78.2) (70.9) (33.0) (68.6) (66.2) (61.0) (54.5) (61.2) (50.7) (41.4) (31.6) (30.6) (43.5) (134.9) (2.6) (0.0)
Income Tax Expense 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2) 0.0 (0.2) (0.1) 0 0 0 0 0
Net Income (42.6) (38.8) (41.4) (50.9) (59.7) (59.9) (66.3) (66.4) (65) (89.3) (62.3) (79.2) (100.0) (94.8) (83.1) (74.8) (79.8) (74.9) (78.2) (70.9) (33.0) (68.6) (66.2) (61.0) (54.5) (61.0) (50.7) (41.2) (31.6) (30.5) (43.5) (134.9) (2.6) (0.0)
Per Share Data
EPS (Basic) -0.18 -0.17 -0.19 -0.23 -0.28 -0.28 -0.32 -0.35 -0.38 -0.51 -0.37 -0.54 -0.68 -0.66 -0.58 -0.52 -0.56 -0.54 -0.57 -0.53 -0.25 -0.53 -0.52 -0.53 -0.50 -0.58 -0.50 -0.41 -0.32 -0.37 -0.38 -1.19 -0.06
EPS (Diluted) -0.18 -0.17 -0.19 -0.23 -0.28 -0.28 -0.32 -0.35 -0.38 -0.51 -0.37 -0.54 -0.68 -0.66 -0.58 -0.52 -0.56 -0.54 -0.57 -0.53 -0.25 -0.53 -0.52 -0.53 -0.50 -0.58 -0.50 -0.41 -0.32 -0.37 -0.38 -1.19 -0.06
Shares Outstanding 240.3 220.6 222.0 218.9 215.4 210.6 209.2 190.0 169.1 168.3 167.6 146.8 144.6 144.1 143.7 143.4 141.4 139.2 137.0 134.8 132.2 129.8 127.1 115.4 109.0 104.8 102.2 99.8 97.3 82.1 113.7 113.7 44.0 44.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2
Current Assets
Cash & Cash Equivalents 30.3 51.7 37.8 52.3 42.5 75.2 51.2 170.7 51.0 83.2 69.2 154.8 109.9 61.9 74.4 96.0 84.5 173.3 190.0 223.5 236.9 183.4 158.1 280.4 135.9 175.1 161.0 650.2 92.7 721.4 83.1 293.9
Short-Term Investments 236.6 198.5 214.4 220.8 237.6 217.3 240.3 274.0 333.8 365.5 396.3 337.2 361.3 455.4 477.9 394.5 364.5 284.0 293.5 364.2 462.7 644.6 682.9 619.3 357.0 355.4 340.3 0 373.4 0 161.1 0
Net Receivables 1.3 1.5 2.1 0 0 0 0 2 1.7 0 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.4 2.3 3.3 3.4 3.1 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 (1.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (147.8) 0 (262.0) 0 0
Other Current Assets 5.1 6.0 6.4 9.5 11.5 10.9 12.9 10.5 0 10.4 7.9 10.1 10.2 11.5 0 0 0 0 0 0 0 0 0 0 0 (2.4) 0 0 0 0 3.1 0
Total Current Assets 273.3 257.7 260.7 282.7 291.6 303.4 304.4 457.1 395.4 459.1 473.5 502.1 481.5 528.8 569.1 513.0 469.7 471.3 502.9 602.2 716.1 845.1 854.1 909.6 504.4 544.6 509.8 511.5 476.6 468.0 247.4 294.3
Non-Current Assets
Property, Plant & Equipment 108.8 112.7 116.8 120.8 127.1 131.3 135.3 150.5 160.4 163.2 181.5 186.7 191.8 196.4 199.7 204.1 177.3 181.0 164.6 164.9 163.3 160.1 144.2 127.0 110.2 100.9 77.4 67.7 52.8 41.6 29.7 3.5
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0.3 0.5 0.6 0.8 0.9 1.1
Long-Term Investments 10.3 8.0 35.2 29.5 55.5 80.7 111.8 11.4 25.4 3.6 47.8 62.5 53.9 76.5 99.2 211.3 298.3 382.4 396.1 344.3 283.9 207.9 212.5 215.5 65.0 63.2 100.7 147.8 214.6 262.0 154.0 0
Other Non-Current Assets 3.5 37.4 27.0 37.6 33.8 33.4 37.6 27.9 5.2 16.9 9.6 19.7 19.7 19.9 19.7 19.2 19.3 16.1 15.6 15.3 15.7 14.6 11.7 6.5 9.0 8.9 7.4 6.5 4.7 1.5 3.2 0
Total Non-Current Assets 122.7 158.2 179.1 187.9 216.4 245.3 284.7 189.8 191.0 183.7 238.9 268.9 265.4 292.8 318.5 434.6 494.9 579.5 576.4 524.6 463.0 382.7 368.4 349.0 184.1 173.2 185.8 222.5 272.7 305.9 187.9 4.6
Total Assets 396.0 415.9 439.8 470.6 508.0 548.7 589.1 646.9 586.4 642.8 712.3 771.0 746.9 821.6 887.6 947.6 964.6 1,050.8 1,079.2 1,126.7 1,179.0 1,227.8 1,222.5 1,258.5 688.5 717.8 695.5 734.0 749.4 773.9 435.2 298.8
Current Liabilities
Account Payables 4.9 4.3 3.7 4.9 5.1 5.4 5.5 12.9 5.8 5.9 6.2 10.2 14.7 13.9 11.0 9.7 8.7 10.3 11.5 11.0 14.9 10.4 10.2 9.1 7.2 9.2 8.0 23.5 13.0 12.3 3.1 1.3
Short-Term Debt 8.4 0 8.0 0 0 0 0 7.2 6.9 0 6.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 139.6 0
Deferred Revenue 0 0 0 0 0 0 0 0 0.1 0.1 0.2 0.2 0.3 0.1 0.9 0.8 0.4 0.2 0.4 0.3 0.2 39.0 0 0 0 0 0 0 0 0 12.9 0
Other Current Liabilities 15.0 20.0 20.0 0 0 12.1 0 (7.2) (6.9) 12.7 (6.6) 0 0 17.9 0 0 0 16.1 0 0 0 13.0 0 0 0 12.4 18.6 5.1 6.7 5.2 6.4 3.1
Total Current Liabilities 28.3 32.5 31.8 31.7 30.0 35.5 32.6 37.3 30.9 37.1 37.6 54.7 59.6 53.7 48.9 44.9 36.9 47.9 53.5 46.0 54.8 94.3 50.1 40.9 26.8 33.1 33.4 38 27.3 29.5 159.5 14.7
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 16.1 15.8 15.5 15.1 11.3 7.8 7.7 7.6 5.2 5.2 1.5 1.5 1.5 5.8 2.0 2.6 3.5 7.8 5.2 5.7 2.8 3.1 2.8 3.2 3.6 4.4 4.8 5.5 6.1 6.8 7.5 2.5
Total Non-Current Liabilities 88.8 90.8 92.6 94.4 92.6 91.0 92.8 94.5 94.1 93.5 91.6 93.3 95.0 101.0 98.7 100.8 72.5 77.7 55.8 56.9 54.4 53.9 53.6 54.2 55.2 55.7 42.5 40.4 40.9 41.2 444.2 2.5
Total Liabilities 117.1 123.4 124.4 126.0 122.6 126.5 125.4 131.8 125.0 130.6 129.2 148.1 154.6 154.7 147.6 145.7 109.4 125.6 109.3 102.9 109.3 148.2 103.8 95.1 82.0 88.8 75.8 78.4 68.1 70.7 603.7 17.2
Stockholders' Equity
Common Stock 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1
Retained Earnings (2,053.3) (2,010.7) (1,971.9) (1,930.5) (1,879.6) (1,819.8) (1,759.9) (1,693.6) (1,627.2) (1,562.2) (1,474.0) (1,412.7) (1,334.7) (1,235.0) (1,141.1) (1,058.0) (983.2) (894.6) (828.5) (750.3) (679.4) (646.3) (577.8) (511.6) (450.6) (396.1) (335.1) (284.4) (243.1) (211.5) (181.0) (137.5)
Accumulated Other Comprehensive Income (0.2) 0.3 0.2 (0.0) 0.0 (0.1) 0.2 (0.8) (0.9) (1.0) (2.4) (3.9) (5.9) (9.9) (13.0) (11.5) (9.2) (2.6) (0.4) (0.3) (0.1) 0.3 1.0 1.8 1.6 1.1 1.9 2.2 1.4 0.3 (0.1) (261.1)
Total Stockholders' Equity 278.9 292.5 315.3 344.6 385.4 422.2 463.7 515.0 461.4 512.2 583.1 622.9 592.3 666.9 740.0 801.9 855.2 925.2 969.9 1,023.8 1,069.8 1,079.6 1,118.7 1,163.4 606.5 629.0 619.7 655.6 681.2 703.2 (168.4) 281.6
Total Liabilities & Equity 396.0 415.9 439.8 470.6 508.0 548.7 589.1 646.9 586.4 642.8 712.3 771.0 746.9 821.6 887.6 947.6 964.6 1,050.8 1,079.2 1,126.7 1,179.0 1,227.8 1,222.5 1,258.5 688.5 717.8 695.5 734.0 749.4 773.9 435.2 298.8
Debt Metrics
Total Debt 81.1 83.3 85.1 79.2 81.3 90.8 85.1 94.2 95.8 95.1 96.7 91.8 99.7 101.1 96.7 98.2 69.0 73.1 50.6 51.2 51.6 53.8 50.8 51.1 51.5 53.0 37.7 34.9 34.8 34.5 165.3 0
Net Debt 50.7 31.6 47.3 26.9 38.8 15.5 33.9 (76.5) 44.8 12.0 27.4 (62.9) (10.2) 39.2 22.3 2.2 (15.5) (100.2) (139.4) (172.3) (185.2) (129.6) (107.3) (229.3) (84.4) (122.1) (123.3) (615.3) (57.9) (686.9) 82.1 (293.9)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4
Operating Activities
Net Income (42.6) (38.8) (41.4) (50.9) (59.7) (59.9) (66.3) (66.4) (65) (89.3) (61.3) (79.2) (100.0) (94.8) (83.1) (74.8) (79.8) (74.9) (78.2) (70.9) (33.0) (68.6) (66.2) (61.0) (54.5) (61.0) (50.7) (41.2) (31.6) (30.5) (43.5) (134.9) (2.6) (0.0)
Depreciation & Amortization 2.9 3.1 3.1 3.1 3.1 3.2 3.2 3.6 3.6 3.5 3.6 3.6 3.5 3.3 3.9 4.8 4.2 4.2 2.6 2.4 1.9 1.8 1.8 1.9 2.0 1.9 1.3 1.1 0.7 0.5 0.5 0.5 0 0
Stock-Based Compensation 0 8.1 8.7 8.7 12.2 12.9 13.4 13.6 11.9 15.2 15.4 16.6 18.8 0 21.1 0 0 0 0 0 16.8 16.5 17.8 16.8 14.2 13.9 12.8 11.5 7.9 5.9 4.6 8.1 0 0
Change in Working Capital 18.4 (0.2) (0.1) (2.2) (8.3) 5.3 21.2 (16.8) (4.4) (3.4) (14.9) (4.4) 7.4 10.8 7.8 5.1 (20.0) 0.0 3.4 3.9 (39.3) 35.0 7.2 14.9 (3.2) (6.5) 2.2 4.7 (7.2) 0.9 (2.3) 10.9 2.6 0.0
Other Non-Cash Items 8.5 0.2 0.1 2.4 (0.2) 1.9 (15.6) 2.3 (1.9) 0.1 0.1 1.5 3.6 18.6 2.7 22.3 27.4 25.2 23.4 23.5 4.2 5.3 1.8 0.7 0.6 1.7 2.4 (0.8) 0.1 1.8 4.0 109.4 0 0
Operating Cash Flow (12.9) (27.6) (29.7) (39.0) (52.9) (36.7) (44.1) (63.6) (55.9) (53.7) (55.5) (61.9) (66.6) (62.1) (47.7) (42.5) (68.2) (45.4) (48.9) (41.2) (49.3) (10.0) (37.6) (26.7) (40.8) (50.3) (31.9) (24.9) (30.3) (21.5) (17.1) (6.0) 0.0 0
Investing Activities
Capital Expenditure (0.0) 0 (0.2) (0.0) (0.1) (0.3) (0.4) 0 (0.0) (0.2) (0.0) (0.3) (1.0) (1.7) (0.2) (1.4) (1.9) (0.7) (3.3) (10.9) (6.5) (17.4) (20.2) (16.1) (12.3) (14.1) (18.4) (7.9) (10.4) (1.3) (1.4) (0.5) 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 (67.6) 34.3 0 0 0 0 0 0 0 0 0 (15.9) 0 0 0 0 0 0 0 0 (21.8) 0 0 0 0
Purchases of Investments (101.7) (28.4) (49.7) (9.9) (50.2) (47.0) (190.8) (42.6) (81.1) (68.7) (199.4) (135.4) (35.1) (47.8) (49.5) (61.7) (89.2) (52.6) (145.4) (180.3) (149.1) (182.2) (213.3) (519.2) (123.0) (89.7) (61.2) (49.4) (52.4) (333.9) 0 0 0 0
Sales/Maturities of Investments 72.1 62.0 61.9 53.8 56.5 102.2 115.2 117.2 103.3 136.3 165.2 152.9 149.1 99.1 74.6 117.1 68.7 82.5 161.8 215.8 268.2 221.8 150.1 106.2 120.3 116.8 158.3 101.7 95.7 21.8 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 67.6 (34.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (5.1) 97.2 52.3 43.3 21.8 (315.4) (2.1) 0 0
Investing Cash Flow (29.6) 33.6 11.9 43.8 6.2 54.9 (76.0) 74.6 22.1 67.5 (34.3) 17.2 112.9 49.6 24.9 54.0 (22.4) 29.2 13.0 24.6 96.8 22.2 (83.4) (429.0) (15.0) 7.9 78.8 44.5 32.9 (313.4) (316.8) (2.6) 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6,075.8 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 3.6 4.0 0 0 2.3 0 0 1.1 0 1.7 0 1.1 0 0 0 0 0 6.0 1.6 3.8 4.5 1.7 56.5 1.6 0.2 0.7 344.5 124.1 152.6 0 0
Financing Cash Flow 21.1 7.9 3.2 5.1 14.0 5.7 0.7 108.6 1.6 0.2 4.3 89.5 1.7 0.0 1.1 0.0 1.8 0.3 2.4 3.2 6.0 13.0 3.9 600.2 16.6 56.5 1.6 0.2 0.7 344.5 274.1 152.6 0 0
Cash Position
Net Change in Cash (21.4) 13.9 (14.5) 9.9 (32.8) 24.0 (119.4) 119.6 (32.1) 13.9 (85.5) 44.8 48.0 (12.5) (21.7) 11.5 (88.8) (16.7) (33.5) (13.4) 53.5 25.2 (117.1) 144.5 (39.2) 14.1 48.4 19.8 3.3 9.7 (59.8) 143.9 0.0 0
Cash at Beginning 51.7 48.1 52.3 52.7 85.5 61.5 181.0 51.0 93.4 79.5 165.1 109.9 72.2 74.4 106.3 84.5 173.3 190.0 223.5 236.9 192.8 167.6 284.7 140.2 179.4 165.3 116.9 97.0 93.7 84.1 143.9 0.0 0 0
Cash at End 30.3 62.0 37.8 62.6 52.7 85.5 61.5 170.7 61.3 93.4 79.5 154.8 120.2 61.9 84.6 96.0 84.5 173.3 190.0 223.5 246.3 192.8 167.6 284.7 140.2 179.4 165.3 116.9 97.0 93.7 84.1 143.9 0.0 0
Free Cash Flow (12.9) (27.6) (29.9) (39.1) (53.0) (37.0) (44.5) (63.6) (55.9) (53.9) (55.5) (62.1) (67.7) (63.8) (47.9) (43.9) (70.1) (46.2) (52.2) (52.1) (55.8) (27.4) (57.8) (42.8) (53.1) (64.4) (50.3) (32.7) (40.7) (22.8) (18.5) (6.6) 0.0 0
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4
Income Statement
Revenue 0 0 0 0 0 0 0 0 0.0 (0.0) 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 38.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (2.9) (3.1) (31.2) 0 (3.1) (3.2) 0 0 (3.5) (0.0) (3.5) 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 38.3 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (46.1) (42.4) (44.9) (56.8) (65.2) (60.5) (71.8) (71.4) (69.5) (85.2) (63.0) (80.5) (99.1) (96.4) (82.5) (76.6) (80.0) (73.9) (77.7) (71.0) (33.2) (69.4) (68.0) (63.2) (57.7) (64.6) (55.0) (46.0) (36.5) (33.0) (22.2) (135.0) (2.6) (0.0)
Net Income (42.6) (38.8) (41.4) (50.9) (59.7) (59.9) (66.3) (66.4) (65) (89.3) (62.3) (79.2) (100.0) (94.8) (83.1) (74.8) (79.8) (74.9) (78.2) (70.9) (33.0) (68.6) (66.2) (61.0) (54.5) (61.0) (50.7) (41.2) (31.6) (30.5) (43.5) (134.9) (2.6) (0.0)
EPS (Diluted) -0.18 -0.17 -0.19 -0.23 -0.28 -0.28 -0.32 -0.35 -0.38 -0.51 -0.37 -0.54 -0.68 -0.66 -0.58 -0.52 -0.56 -0.54 -0.57 -0.53 -0.25 -0.53 -0.52 -0.53 -0.50 -0.58 -0.50 -0.41 -0.32 -0.37 -0.38 -1.19 -0.06
Balance Sheet
Cash & Equivalents 30.3 51.7 37.8 52.3 42.5 75.2 51.2 170.7 51.0 83.2 69.2 154.8 109.9 61.9 74.4 96.0 84.5 173.3 190.0 223.5 236.9 183.4 158.1 280.4 135.9 175.1 161.0 650.2 92.7 721.4 83.1 293.9
Total Assets 396.0 415.9 439.8 470.6 508.0 548.7 589.1 646.9 586.4 642.8 712.3 771.0 746.9 821.6 887.6 947.6 964.6 1,050.8 1,079.2 1,126.7 1,179.0 1,227.8 1,222.5 1,258.5 688.5 717.8 695.5 734.0 749.4 773.9 435.2 298.8
Total Debt 81.1 83.3 85.1 79.2 81.3 90.8 85.1 94.2 95.8 95.1 96.7 91.8 99.7 101.1 96.7 98.2 69.0 73.1 50.6 51.2 51.6 53.8 50.8 51.1 51.5 53.0 37.7 34.9 34.8 34.5 165.3 0
Stockholders' Equity 278.9 292.5 315.3 344.6 385.4 422.2 463.7 515.0 461.4 512.2 583.1 622.9 592.3 666.9 740.0 801.9 855.2 925.2 969.9 1,023.8 1,069.8 1,079.6 1,118.7 1,163.4 606.5 629.0 619.7 655.6 681.2 703.2 (168.4) 281.6
Cash Flow
Operating Cash Flow (12.9) (27.6) (29.7) (39.0) (52.9) (36.7) (44.1) (63.6) (55.9) (53.7) (55.5) (61.9) (66.6) (62.1) (47.7) (42.5) (68.2) (45.4) (48.9) (41.2) (49.3) (10.0) (37.6) (26.7) (40.8) (50.3) (31.9) (24.9) (30.3) (21.5) (17.1) (6.0) 0.0 0
Capital Expenditure (0.0) 0 (0.2) (0.0) (0.1) (0.3) (0.4) 0 (0.0) (0.2) (0.0) (0.3) (1.0) (1.7) (0.2) (1.4) (1.9) (0.7) (3.3) (10.9) (6.5) (17.4) (20.2) (16.1) (12.3) (14.1) (18.4) (7.9) (10.4) (1.3) (1.4) (0.5) 0 0
Free Cash Flow (12.9) (27.6) (29.9) (39.1) (53.0) (37.0) (44.5) (63.6) (55.9) (53.9) (55.5) (62.1) (67.7) (63.8) (47.9) (43.9) (70.1) (46.2) (52.2) (52.1) (55.8) (27.4) (57.8) (42.8) (53.1) (64.4) (50.3) (32.7) (40.7) (22.8) (18.5) (6.6) 0.0 0